Healthcare Services

Flow Cytometry In Oncology And Immunology Market Size Outlook and Demand Growth Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Flow Cytometry In Oncology And Immunology Market Over The 2026–2030 Period?

The flow cytometry in oncology and immunology market has seen swift expansion recently. It is anticipated to grow from $2.32 billion in 2025 to $2.56 billion in 2026, at a compound annual growth rate (CAGR) of 10.2%. The historical increase can be attributed to a surge in cancer research funding, the broadening of immunotherapy development, the provision of advanced cytometry platforms, heightened clinical trial operations, and a rising necessity for immune monitoring.

The flow cytometry in oncology and immunology market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $3.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This growth over the forecast period is fueled by factors such as the increasing demand for personalized oncology diagnostics, the integration with genomic data, the expansion of immuno-oncology therapies, the broadening of clinical research pipelines, and advancements in multiplex analysis. Key developments anticipated during this time involve the rising use in cancer biomarker identification, increased adoption in immune cell profiling, the expansion of minimal residual disease detection, a growing application in translational research, and the integration of high-dimensional data analysis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Underlying Factors Are Accelerating The Growth Of The Flow Cytometry In Oncology And Immunology Market?

The increasing incidence of HIV/AIDS is anticipated to drive the expansion of flow cytometry within the oncology and immunology market in the foreseeable future. HIV, a virus, targets the body’s immune system, particularly CD4 cells, which are vital white blood cells involved in combating infections. If left untreated, HIV can progress to AIDS, representing the advanced stage of the HIV infection. In both HIV/AIDS research and clinical environments, flow cytometry serves as an effective method for analyzing and characterizing cells, especially immune cells, by assessing their physical and chemical attributes. This technique enables the identification of T cells that are latently infected, meaning they contain the HIV genome but are not actively generating the virus. For example, in July 2024, data from UNAIDS, a UN program based in Switzerland, indicated that approximately 39.9 million individuals worldwide were living with HIV in 2023, an increase from 39.0 million in 2022. Consequently, the growing prevalence of HIV/AIDS is boosting the flow cytometry sector within the oncology and immunology market.

How Is The Flow Cytometry In Oncology And Immunology Market Segmented Across Key Categories?

The flow cytometry in oncology and immunology market covered in this report is segmented –

1) By Type: Immunology, Oncology

2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry

3) By Application: Translational Research, Clinical Research

4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:

1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing

2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Which Market Trends Are Creating New Opportunities In The Flow Cytometry In Oncology And Immunology Market?

Companies at the forefront of the flow cytometry domain within the oncology and immunology market are concentrating on developing innovative solutions, such as spectral flow cytometry, to achieve a competitive advantage. Spectral flow cytometry is a technique that records the complete emission spectrum of each fluorescent marker, rather than detecting fixed, narrow-band signals, thereby enabling significantly higher parameter, multiparametric cell analysis. For instance, in May 2024, Agilent Technologies, a US-based life science company, launched the NovoCyte Opteon spectral flow cytometer. This device supports three to five lasers, incorporates up to 73 detectors, and permits the analysis of more than 40 markers in a single run. This system bolsters the capacity for extensive immunophenotyping in oncology and immunology research. Its benefits include flexibility in panel design, reduced spectral overlap, and improved signal resolution; however, it demands more complex data unmixing algorithms, potentially increasing the time required for analysis.

Who Are The Dominant Players Shaping The Flow Cytometry In Oncology And Immunology Market Landscape?

Major companies operating in the flow cytometry in oncology and immunology market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, Miltenyi Biotec, Luminex Corporation, Q2 Solutions LLC, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Read the full flow cytometry in oncology and immunology market report here:

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Which Region Is Projected To Dominate The Flow Cytometry In Oncology And Immunology Market During The Forecast Period?

North America was the largest region in the flow cytometry in oncology and immunology market in 2025. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Flow Cytometry In Oncology And Immunology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Browse Through More Reports Similar to the Global Flow Cytometry In Oncology And Immunology Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Global Market Report

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Flow Chemistry Global Market Report

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Lateral Flow Assays Global Market Report

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795